(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMAS CRISTALINAS DE LENALIDOMIDA

ArquivadaInvention PatentPCT · IB2018057500

Application data

Number

112020006051

Type

Invention Patent

Filing

09/27/2018

Publication

10/06/2020

PCT

IB2018057500

Progress at the INPI

  1. Filing09/27/18
  2. Publication10/06/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 11/29/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BIOCON LIMITED

IN

See this company's full portfolio

Inventors

L. M. (pessoa física)

IN

R. B. (pessoa física)

IN

V. P. (pessoa física)

IN

V. R. (pessoa física)

IN

Technical data

Priority claims

IN

201741034364 · 09/27/2017

Abstract

A presente invenção fornece novos co-cristais de lenalidomida. A presente invenção fornece particularmente cocristalinos de lenalidomida com Resorcinol. Metil parabeno e sacarina. A presente invenção fornece ainda processos para a preparação da Forma IV de lenalidomida cristalina anidra.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

11/29/2022

RPI 2708

Parecer de pré-exame

#6.23

08/16/2022

RPI 2693

Adição na publicação

#15.35

11/23/2021

RPI 2655

Notificação de entrada na fase nacional - PCT

#1.3

10/06/2020

RPI 2596

Alteração de dados cadastrais

#1.1

09/15/2020

RPI 2593

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.